Evidence map›Paper›PMID 18533367›Full record

ReviewDrug metabolism and drug interactions2008

Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease.

Paul J Thornalley

Open access · greenAbstract readReview
In one paragraph

Review in Drug metabolism and drug interactions, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 210 papers.

0numbers the graph read from it
0cells of the map it votes in
210citing papers in PubMed
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

210 citing papers in PubMed, 465 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Methylglyoxal Affects Dopamine Homeostasis in SH-SY5Y Cells Through the Modulation of miR-190a and miR-214.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Implication ofInternational journal of molecular sciences · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Article

150 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Paul J ThornalleyProtein Damage and Systems Biology Research Group, Clinical Sciences Research Institute, Warwick Medical School, University of Warwick, University Hospital, Coventry, UK. P.J.Thornalley@warwick.ac.uk
University of Warwick · GB

Funding

Biotechnology and Biological Sciences Research Council BB/D006295/2Cancer Research UK A5147Wellcome Trust
6 · The paper itself

Abstract

Glycation of proteins, nucleotides and basic phospholipids by glyoxal and methylglyoxal--physiological substrates of glyoxalase 1--is potentially damaging to the proteome, genome and lipidome. Glyoxalase 1 suppresses glycation by these alpha-oxoaldehyde metabolites and thereby represents part of the enzymatic defence against glycation. Albert Szent-Györgyi pioneered and struggled to understand the physiological function of methylglyoxal and the glyoxalase system. We now appreciate that glyoxalase 1 protects against dicarbonyl modifications of the proteome, genome and lipome. Latest research suggests there are functional modifications of this process--implying a role in cell signalling, ageing and disease.

Indexed as

AgingAnimalsDrug Resistance, NeoplasmGlycation End Products, AdvancedGlyoxalHumansHydroxyacylglutathione HydrolaseLactoylglutathione LyaseNucleotidesProteinsPyruvaldehydeThiolester HydrolasesGlycation End Products, AdvancedGlyoxalHydroxyacylglutathione HydrolaseLactoylglutathione LyaseNucleotidesProteinsPyruvaldehydeThiolester Hydrolases

Identifiers

PMID18533367
PMCPMC2649415
OpenAlexW2059681268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.